THE DIFFERENTIATION SYNDROME IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA: EXPERIENCE OF THE PETHEMA GROUP AND REVIEW OF THE LITERATURE.
<p>Differentiation syndrome (DS), formerly known as retinoic acid syndrome, is the main life-threatening complication of therapy with differentiating agents (all-<em>trans</em> retinoic acid [ATRA] or arsenic trioxide [ATO]) in patients with acute promyelocy...
Saved in:
| Main Authors: | Pau Montesinos, Miguel A Sanz |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2011-01-01
|
| Series: | Mediterranean Journal of Hematology and Infectious Diseases |
| Subjects: | |
| Online Access: | http://www.mjhid.org/article/view/9536 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
THE DIFFERENTIATION SYNDROME IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA: EXPERIENCE OF THE PETHEMA GROUP AND REVIEW OF THE LITERATURE.
by: Pau Montesinos, et al.
Published: (2011-12-01) -
Challenging management of severe differentiation syndrome in pediatric acute promyelocytic leukemia treated with ATRA/ATO
by: Alessandro Molinaro, et al.
Published: (2022-02-01) -
ACUTE PROMYELOCYTIC LEUKEMIA IN CHILDREN: A SINGLE CENTRE EXPERIENCE FROM TURKEY
by: Tekin Aksu
Published: (2018-07-01) -
Acute promyelocytic leukemia can be fully treated on an outpatient basis: a single institution experience
by: Danae García-Vélez, et al.
Published: (2024-12-01) -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
by: Neil Osheroff, et al.
Published: (2011-01-01)